Skip to main content
. 2023 Aug 30;43(3):293–304. doi: 10.1055/a-2133-8614

Fig. 4.

Fig. 4

HDV therapies in development (modified from Sandmann and Cornberg, 2021 98 ). cccDNA, covalently closed circular DNA; EU, European Union; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HDV, hepatitis delta virus; hNTCP, human sodium taurocholate cotransporting polypeptide; L-HDAg, large hepatitis D antigen.